Opendata, web and dolomites


Preclinical development of squalenic acid and gemcitabine squalene nanomedicine

Total Cost €


EC-Contrib. €






 SQUALAC project word cloud

Explore the words cloud of the SQUALAC project. It provides you a very rough idea of what is the project "SQUALAC" about.

spacer    toxic    release    template    data    deserve    natural    remarkable    sqco2h    squalenoylation    van    sq    candidate    anticancer    perform    innovation    cro3    preparation    acceptable    clinical    platform    synthesis    impressive    acid    drugs    ing    loading    bioconjugate    compound    incidentally    folded    employed    translation    lock    regulatory    gem    linkage    shown    reaction    pancreatic    triggered    moiety    chemical    remarkably    cosmetics    raquo    chemistry    itself    overcome    goals    display    nanoparticles    cancer    hunting    bioconjugates    yield    never    poor    disease    molecular    devastating    tumors    confers    shark    resistance    property    laquo    conformation    discovered    nanomedicine    environmental    excipient    clinic    erc    drug    parent    self    treatment    squalenic    total    construct    gemcitabine    economical    grant    experimental    efficient    green    lipid    nanomedicines    course    excessive    tumor    ternanomed    therapy    squalene    first    assemble    pharmaceutical    tamelen   

Project "SQUALAC" data sheet

The following table provides information about the project.


Organization address
postcode: 91405

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 150˙000 €
 EC max contribution 150˙000 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2014-PoC
 Funding Scheme ERC-POC
 Starting year 2015
 Duration (year-month-day) from 2015-03-01   to  2016-08-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITE PARIS-SUD FR (ORSAY CEDEX) coordinator 150˙000.00


 Project objective

'In the course of the ERC Advanced Grant TERNANOMED, we have discovered that the linkage of squalene (a natural lipid) to many drugs, confers to the resulting bioconjugates the remarkable property to self-assemble as nanoparticles, due to the folded molecular conformation of squalene. This approach is unique and has never been used before. The so called 'squalenoylation' technology may be considered as a generic platform to construct nanomedicines with high drug loading and targeted drug release triggered by the spacer between the drug and the squalene moiety. Remarkably, it was shown that these nanomedicines were more efficient and less toxic than the parent drugs. The gemcitabine-squalene (Gem-SQ) nanomedicine, our first candidate for further pharmaceutical developments, was shown not only to display an impressive anticancer activity in experimental tumors but also to overcome drug resistance, thus addressing a major challenge in tumor therapy. These pre-clinical data deserve further development towards translation into the clinic for the treatment of the pancreatic cancer, a devastating disease. However, the squalenic acid (SQCO2H), the chemical template essential for the synthesis of the Gem-SQ bioconjugate, is currently obtained through the Van Tamelen reaction which cannot be employed for the preparation of a clinical sample of Gem-SQ, because of the use of CrO3 (a toxic compound) and the poor yield of the reaction. Therefore, the synthesis of SQCO2H represents a lock for further clinical development of our Gem-SQ nanomedicine. The goals of the present proposal are : (i) to perform the total synthesis of SQCO2H through a new « green » chemistry way (which represents in itself a real innovation) allowing (ii) further regulatory acceptable preparation of Gem-SQ nanoparticles. Incidentally, the total synthesis of SQCO2H will avoid environmental concern due to excessive shark hunting and represents by itself some economical value as excipient for the cosmetics.'

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SQUALAC" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SQUALAC" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

InsideChromatin (2019)

Towards Realistic Modelling of Nucleosome Organization Inside Functional Chromatin Domains

Read More  

SuperH (2019)

Discovery and Characterization of Hydrogen-Based High-Temperature Superconductors

Read More  


The Enemy of the Good: Towards a Theory of Moral Progress

Read More